Literature DB >> 3337731

Primary structure of nonspecific crossreacting antigen (NCA), a member of carcinoembryonic antigen (CEA) gene family, deduced from cDNA sequence.

Y Tawaragi1, S Oikawa, Y Matsuoka, G Kosaki, H Nakazato.   

Abstract

A cDNA containing the entire coding region for a member of carcinoembryonic antigen (CEA) gene family has been cloned from cDNA library of HLC-1 cells by immunochemical screening with the antibody specific to nonspecific crossreacting antigen (NCA). The cDNA encodes a precursor form of a polypeptide consisting of a 34-residue signal sequence, a 108-residue N-terminal (N-) domain, a 178-residue domain (NCA-I domain) and a 24-residue domain rich in hydrophobic amino acids (M-domain). Each domain has a distinct but homologous amino acid sequence to that of the corresponding domain of CEA. Unlike the coding sequences, the 3'-untranslated sequences differ markedly in the NCA and CEA cDNAs facilitating the preparation of probes that will discriminate between nucleotide sequences for CEA and NCA.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3337731     DOI: 10.1016/0006-291x(88)90490-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Binding of nonspecific cross-reacting antigen, a granulocyte membrane glycoprotein, to Escherichia coli expressing type 1 fimbriae.

Authors:  S L Sauter; S M Rutherfurd; C Wagener; J E Shively; S A Hefta
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

2.  Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins.

Authors:  R K Williams; G S Jiang; K V Holmes
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

3.  Intra- and interspecies analyses of the carcinoembryonic antigen (CEA) gene family reveal independent evolution in primates and rodents.

Authors:  F Rudert; W Zimmermann; J A Thompson
Journal:  J Mol Evol       Date:  1989-08       Impact factor: 2.395

4.  Pregnancy specific beta 1-glycoprotein in human intestine.

Authors:  W L Shupert; W Y Chan
Journal:  Mol Cell Biochem       Date:  1993-03-24       Impact factor: 3.396

5.  Cloning of the complete gene for carcinoembryonic antigen: analysis of its promoter indicates a region conveying cell type-specific expression.

Authors:  H Schrewe; J Thompson; M Bona; L J Hefta; A Maruya; M Hassauer; J E Shively; S von Kleist; W Zimmermann
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

6.  The MRC OX-45 antigen of rat leukocytes and endothelium is in a subset of the immunoglobulin superfamily with CD2, LFA-3 and carcinoembryonic antigens.

Authors:  N Killeen; R Moessner; J Arvieux; A Willis; A F Williams
Journal:  EMBO J       Date:  1988-10       Impact factor: 11.598

7.  Carcinoembryonic antigens: alternative splicing accounts for the multiple mRNAs that code for novel members of the carcinoembryonic antigen family.

Authors:  T R Barnett; A Kretschmer; D A Austen; S J Goebel; J T Hart; J J Elting; M E Kamarck
Journal:  J Cell Biol       Date:  1989-02       Impact factor: 10.539

8.  Establishment and characterisation of human carcinoembryonic antigen transgenic mice.

Authors:  T Hasegawa; K Isobe; Y Tsuchiya; S Oikawa; H Nakazato; H Ikezawa; I Nakashima; K Shimokata
Journal:  Br J Cancer       Date:  1991-10       Impact factor: 7.640

9.  Expression of carcinoembryonic antigen (CEA) and nonspecific crossreacting antigen (NCA) in gastrointestinal cancer; the correlation with degree of differentiation.

Authors:  Y Kodera; K Isobe; M Yamauchi; T Satta; T Hasegawa; S Oikawa; K Kondoh; S Akiyama; K Itoh; I Nakashima
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

10.  Nonspecific crossreacting antigen (NCA) is a major member of the carcinoembryonic antigen (CEA)-related gene family expressed in lung cancer.

Authors:  T Hasegawa; K Isobe; Y Tsuchiya; S Oikawa; H Nakazato; I Nakashima; K Shimokata
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.